Compliance barriers in glaucoma: a systematic classification.
about
Interventions for improving adherence to ocular hypotensive therapyInterventions for improving adherence to ocular hypotensive therapyQuality of Life in Glaucoma: A Review of the LiteratureHow 'Drug Aware' are our Glaucoma Patients?Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focusThe Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional SurveyMedical Management of Glaucoma in the 21st Century from a Canadian PerspectiveCritical evaluation of latanoprostene bunod in the treatment of glaucomaMedical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency.Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ) in glaucoma using a qualitative studyPredictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combinationAn exploratory study of factors influencing glaucoma treatment adherenceLong-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study.An objective assessment of the variability in number of drops per bottle of glaucoma medication.Glaucoma patients' trust in the physicianAdjunctive therapy patterns in glaucoma patients using prostaglandin analogs.Prevalence of self-reported early glaucoma eye drop bottle exhaustion and associated risk factors: a patient surveyEfficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.Factors associated with adherence to glaucoma pharmacotherapy in the primary care settingSafety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapyOcular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice.Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure.The effect of medical therapy on IOP control in GhanaPredictors of adherence to glaucoma treatment in a multisite study.Travoprost 0.004%/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacy.Determinants of medication adherence to topical glaucoma therapy.Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucomaGlaucoma patient expression of medication problems and nonadherence.The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma.Impact of the introduction of generic latanoprost on glaucoma medication adherence.Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic MonitorsCurrent and emerging medical therapies for glaucoma.Attributes Associated with Adherence to Glaucoma Medical Therapy and its Effects on Glaucoma Outcomes: An Evidence-Based Review and Potential Strategies to Improve Adherence.Health coaching for glaucoma care: a pilot study using mixed methods.Exploring the influence of patient-provider communication on intraocular pressure in glaucoma patients.Adherence to ocular hypotensive therapy: patient health education needs and views on group educationWhy Patients With Glaucoma Lose Vision: The Patient Perspective.Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/timolol among patients with open-angle glaucoma or ocular hypertension
P2860
Q24197680-E591AA46-74E0-445D-A824-CB3E832D5577Q24241641-FA3F393B-A027-4F0F-88A9-8FE8E4F34BEFQ26747891-61E9AFBE-53B8-4527-ADB7-6F3D04A566BBQ26753173-916AE29A-4B2F-4FF4-91CC-6BC0EAC2B8DAQ26830201-1E6BD66A-D07E-411A-AB6D-E9F15D881C7DQ27304716-5372FFB1-CF20-4E8A-B70E-31DB67C4444CQ28074316-D6130406-8540-41F4-A11C-3B009A2B0D5FQ28077208-8F5CC91B-2230-41D9-9568-68E7FEA64F44Q30890274-45A84817-FB08-4A62-8697-31F4B139800FQ33293442-1E00997C-910A-452C-A800-C938119B5F3DQ33546682-4B31A3BF-467C-475D-800E-431AEEEAC5DFQ33597692-2B76CE63-886E-41B7-9375-F29C68621ECEQ33687798-01EC86BF-73E7-48FA-B6B7-27A930811679Q33717101-63C8B010-2906-4C23-874E-C0E7C31742C2Q33720403-248834BE-06DE-4CA8-9F55-8E19DF95FD91Q33769480-603157FB-F6A1-4895-A4E2-79A0BAE2CCB0Q33812135-08AECAE4-7635-4193-9D0D-8B0FFA6BD164Q33857744-E9B6C2B1-FE61-4DFC-BDFD-A903E7AD3E3EQ33931543-0888B43F-CF4D-411A-963B-B2B73255BABDQ34090075-B04D24C9-D63D-45C3-9E9F-BAB524BF8360Q34357225-8229CD7E-AABA-4013-A806-F2EA64086364Q34729093-C69A1BB6-9E44-4E67-99A4-FFBC87C0AF8AQ34953629-B6120AB0-143D-40F4-B8B4-CB814EFA9923Q35104629-80B6FBB5-B709-4C6A-B26E-0050A5E6E1C0Q35108156-B6E8CDB7-6748-46B7-9DF2-E3F3D1AE63BCQ35227003-AE5F9C4D-F4C4-485E-A759-BB6D881842BDQ35243409-F83A9C4C-AC76-4877-BDCE-7049C177B95FQ35500843-8C3CF9CD-2810-4335-9BE3-4C142D092E8EQ35537191-C738DC7A-943B-4349-95D9-A26E47955168Q35571666-8D189E95-F8AD-4FD1-A82E-0094F756C13AQ35681331-1E67B430-F77D-404A-8244-4051B0DA38ABQ35899865-207A5FC7-EF45-4981-B0F4-93110B0DE957Q36055050-272FED77-33B8-4ECA-BE76-13BA5AAB0EDFQ36066033-54F67267-3892-4682-89A8-730A006D14F3Q36177075-2E351AAB-B4C9-4284-8344-9F9AE693FB82Q36239996-A7EA87D4-FC72-4443-87B5-B48926F0069AQ36437242-1C87E18C-4E30-4868-89E8-0E4B6BD4BFB3Q36557239-2677C7FE-C297-41AD-98B2-BDD3214D732AQ36626069-C38A13C3-BD68-4827-8967-C5F904C80175Q36627716-B27B3A1B-DADE-417A-945F-1270C8EA3B1B
P2860
Compliance barriers in glaucoma: a systematic classification.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Compliance barriers in glaucoma: a systematic classification.
@en
Compliance barriers in glaucoma: a systematic classification.
@nl
type
label
Compliance barriers in glaucoma: a systematic classification.
@en
Compliance barriers in glaucoma: a systematic classification.
@nl
prefLabel
Compliance barriers in glaucoma: a systematic classification.
@en
Compliance barriers in glaucoma: a systematic classification.
@nl
P2093
P1433
P1476
Compliance barriers in glaucoma: a systematic classification.
@en
P2093
Cori A McClure
David G Schlundt
James C Tsai
James W Pichert
Sarah E Ramos
P304
P356
10.1097/00061198-200310000-00001
P577
2003-10-01T00:00:00Z